PMV Pharmaceuticals, Inc.’s Post

Accelerated approvals, staying abreast of rapid changes in data and navigating regulatory intricacies further complicate the commercialization process for #oncology therapies. Consequently, challenges such as infrastructure, risk spend and communicating value emerge as significant challenges. In their latest article, EVERSANA’s experts provide considerations and innovative approaches for brands to enhance their commercialization strategies. Read now: https://ow.ly/4emF50QRnV0

Why is prioritization in clinical trials a game-changer? 🤔 Join an interactive Roundtable Discussion on “Optimizing Resource Allocation: Why Prioritization Matters in Clinical Trial?” at our Upcoming Conference in Boston, on October 16-18, 2024. Rebecca Rudicell, PhD, Translational Program Management, Takeda, Stephen Smith, Senior Program Director, Oncology, Corcept Therapeutics will lead this session, exploring the crucial role of strategic prioritization. Learn how to align resources with high-potential trials for efficient use of time, budget, and expertise. Ready to optimize your clinical trial portfolio? Register now: https://lnkd.in/dmKigmrk #PPM #Boston #ClinicalTrials #ResourceAllocation

Better disease models with 3D cell models. With theRASTRUM™ platform, the transition from 2D to 3D cell models is not as big as you think! #cancerresearch #tme #3Dcellmodels #RASTRUM

Champions Oncology is exhibiting at #AACR24 and presenting 9 novel research posters. Remember to stop by our new Booth #241, to learn more about our innovative platforms and services. Schedule a meeting with our team to discuss how our revolutionary platforms can transform your preclinical and clinical research: https://hubs.li/Q02kvPT90 #oncologyresearch #clinicaltrials #clinicalspecialtytesting #multiomics #bioinformatics #PDXmodels #3Dtumormodels

How aligned is your precision oncology growth strategy with the evolving needs of your customers?🧬 Delve into groundbreaking opportunities in precision oncology, driven by industry shifts and innovations.📈 🔗Click here position your organization at the forefront of precision oncology innovation! https://hubs.la/Q02BRl970 #PrecisionOncology #GrowthStrategy #HealthcareInnovation #Oncology #MedicalResearch #HealthcareIndustry

Are you eager to understand the role of invitro and invivo research in cancer research? We invite you to join the webinar by our panel of experts Eby John and Dr. Shahzada Asad to know more. Register on the link 👇 #cancerresearch #invitroresearch #invivoresearch #cellimaging #revvity

With over 25 years of experience in research, technology, and biotech, Noelle Gaskill of Mirati Therapeutics approaches the challenges of DCTs with a comprehensive perspective, prioritizing listening to research sites. Get a sneak peek into her #ACRP2024 session, where she shares tactical insights from collaborating with thought-leaders, regulators, and sites, aiming to launch a hybrid DCT interventional oncology trial this year. Learn more about Noelle's session in Anaheim > https://bit.ly/3T5ahLX #GoForIt #GoForEducation #ClinicalTrials #ClinicalResearch #ClinicalTrialDesign #DCT #DecentralizedClinicalTrials

If your firm pursues clients in biotechnology, health diagnostics, or life science, you should watch this episode of Marketer’s Edge. In this episode, Mark Sneider talks oncology, health diagnostics & biotechnology with Farida Peters-Abbadi, Vice President of Marketing at Agendia.